It is reassuring to recognise that current evidence suggests the virus is unlikely to bind to the ocular surface to initiate infection, and that the ocular manifestations such as conjunctivitis and presence of SARS‐CoV‐2 in tears have so far only been found rarely and primarily in people with confirmed, symptomatic COVID‐19.